HEALTHCARE PROFESSIONALS

Cost Saving

Up to 56% savings on the cost of category C quetiapine XL  prescriptions by prescribing Biquelle XL.2**

By prescribing Biquelle XL by brand, the average savings for a CCG could be more than £52,795 per year providing the NHS with a total potential annual prescribing cost saving of more than £8.5 million.1*

Biquelle XL Cost Calculator

To find out how much you can save by prescribing Biquelle XL, please follow the instructions on the Biquelle XL calculator:


Biquelle XL is part of the cost-saving prolonged-release product range from Aspire Pharma.

  • Up to 56% savings on Category C Drug Tariff prices;2**
  • Available from mainline wholesalers;
  • High level of stockholdings;
  • Price guaranteed until 2024***
  • Bioequivalent to the originator.3
ProductCategory C UK Drug Tariff price2Biquelle XL Price
Quetiapine prolonged-release tablets 50mg x 60 £67.66 £29.45
Quetiapine prolonged-release tablets 150mg x 60£113.10 £49.45
Quetiapine prolonged-release tablets 200mg x 60£113.10 £49.45
Quetiapine prolonged-release tablets 300mg x 60£170.00£74.45
Quetiapine prolonged-release tablets 400mg x 60£226.20 £98.95
Quetiapine prolonged-release tablets 600mg x 30 £70.73 £70.73
Potential still to save based on the market data in reference 1 for 161 CCGs switching their generic and brand originator quetiapine prolonged-release tablet prescriptions to Biquelle XL. **Based on 56% saving when prescribing Biquelle XL 50, 150, 200, 300 and 400mg tablets only, versus the cost of Category C quetiapine XL on the UK Drug Tariffs. ***No change in price subject to no material change to the products or Category C of the UK Drug Tariff until the 2024 PPRS review.
References: 1) Insypher data GPPLPD Date Range: Jun20 -Aug 20 MQT*4  2) May 2021 UK Drug Tariffs (Accessed May 2021). 3) Data on file. 1010067149 v 4.0 October 2019
TRUSTED BRANDS.
DEPENDABLE SUPPLY CHAIN.
For further information please call: 01730 231148,
email: customerservices@aspirepharma.co.uk or visit www.aspirepharma.co.uk
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148

For more information about Biquelle XL, please see the abbreviated prescribing information.

Revision reference – Biquelle XL_18_03.05.21

More products available
in this range:
Click to view their
individual websites